170 related articles for article (PubMed ID: 10952023)
1. Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer/testis antigen.
Debinski W; Gibo DM
Mol Med; 2000 May; 6(5):440-9. PubMed ID: 10952023
[TBL] [Abstract][Full Text] [Related]
2. Novel anti-brain tumor cytotoxins specific for cancer cells.
Debinski W; Gibo DM; Obiri NI; Kealiher A; Puri RK
Nat Biotechnol; 1998 May; 16(5):449-53. PubMed ID: 9592393
[TBL] [Abstract][Full Text] [Related]
3. Molecular targeting of malignant gliomas with novel multiply-mutated interleukin 13-based cytotoxins.
Nash KT; Thompson JP; Debinski W
Crit Rev Oncol Hematol; 2001; 39(1-2):87-98. PubMed ID: 11418305
[TBL] [Abstract][Full Text] [Related]
4. Receptor for interleukin 13 is abundantly and specifically over-expressed in patients with glioblastoma multiforme.
Debinski W; Gibo DM; Slagle B; Powers SK; Gillespie GY
Int J Oncol; 1999 Sep; 15(3):481-6. PubMed ID: 10427128
[TBL] [Abstract][Full Text] [Related]
5. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.
Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY
J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073
[TBL] [Abstract][Full Text] [Related]
6. Growth factor receptor expression varies among high-grade gliomas and normal brain: epidermal growth factor receptor has excellent properties for interstitial fusion protein therapy.
Liu TF; Tatter SB; Willingham MC; Yang M; Hu JJ; Frankel AE
Mol Cancer Ther; 2003 Aug; 2(8):783-7. PubMed ID: 12939468
[TBL] [Abstract][Full Text] [Related]
7. Novel way to increase targeting specificity to a human glioblastoma-associated receptor for interleukin 13.
Debinski W; Gibo DM; Puri RK
Int J Cancer; 1998 May; 76(4):547-51. PubMed ID: 9590132
[TBL] [Abstract][Full Text] [Related]
8. Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL13Ralpha2 as a decoy receptor for IL13.
Bernard J; Treton D; Vermot-Desroches C; Boden C; Horellou P; Angevin E; Galanaud P; Wijdenes J; Richard Y
Lab Invest; 2001 Sep; 81(9):1223-31. PubMed ID: 11555670
[TBL] [Abstract][Full Text] [Related]
9. Receptor for interleukin (IL) 13 does not interact with IL4 but receptor for IL4 interacts with IL13 on human glioma cells.
Debinski W; Miner R; Leland P; Obiri NI; Puri RK
J Biol Chem; 1996 Sep; 271(37):22428-33. PubMed ID: 8798406
[TBL] [Abstract][Full Text] [Related]
10. Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells.
Kahlon KS; Brown C; Cooper LJ; Raubitschek A; Forman SJ; Jensen MC
Cancer Res; 2004 Dec; 64(24):9160-6. PubMed ID: 15604287
[TBL] [Abstract][Full Text] [Related]
11. Mutants of interleukin 13 with altered reactivity toward interleukin 13 receptors.
Thompson JP; Debinski W
J Biol Chem; 1999 Oct; 274(42):29944-50. PubMed ID: 10514477
[TBL] [Abstract][Full Text] [Related]
12. An immune regulatory cytokine receptor and glioblastoma multiforme: an unexpected link.
Debinski W
Crit Rev Oncog; 1998; 9(3-4):255-68. PubMed ID: 10201630
[TBL] [Abstract][Full Text] [Related]
13. Suppression of human glioma xenografts with second-generation IL13R-specific chimeric antigen receptor-modified T cells.
Kong S; Sengupta S; Tyler B; Bais AJ; Ma Q; Doucette S; Zhou J; Sahin A; Carter BS; Brem H; Junghans RP; Sampath P
Clin Cancer Res; 2012 Nov; 18(21):5949-60. PubMed ID: 22966020
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha.
Malabarba MG; Rui H; Deutsch HH; Chung J; Kalthoff FS; Farrar WL; Kirken RA
Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):865-72. PubMed ID: 8920992
[TBL] [Abstract][Full Text] [Related]
15. Alanine-scanning mutagenesis of alpha-helix D segment of interleukin-13 reveals new functionally important residues of the cytokine.
Madhankumar AB; Mintz A; Debinski W
J Biol Chem; 2002 Nov; 277(45):43194-205. PubMed ID: 12189139
[TBL] [Abstract][Full Text] [Related]
16. Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas.
Debinski W; Gibo DM; Hulet SW; Connor JR; Gillespie GY
Clin Cancer Res; 1999 May; 5(5):985-90. PubMed ID: 10353730
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas.
Joshi BH; Plautz GE; Puri RK
Cancer Res; 2000 Mar; 60(5):1168-72. PubMed ID: 10728667
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 13 mutants of enhanced avidity toward the glioma-associated receptor, IL13Ralpha2.
Madhankumar AB; Mintz A; Debinski W
Neoplasia; 2004; 6(1):15-22. PubMed ID: 15068667
[TBL] [Abstract][Full Text] [Related]
19. Allergy-related polymorphisms influence glioma status and serum IgE levels.
Wiemels JL; Wiencke JK; Kelsey KT; Moghadassi M; Rice T; Urayama KY; Miike R; Wrensch M
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1229-35. PubMed ID: 17548690
[TBL] [Abstract][Full Text] [Related]
20. The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy.
Shimamura T; Husain SR; Puri RK
Neurosurg Focus; 2006 Apr; 20(4):E11. PubMed ID: 16709016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]